Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001104659-25-014220
Filing Date
2025-02-14
Accepted
2025-02-14 16:33:26
Documents
6

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 31871
2 EXHIBIT 99.1 tm254155d6_ex99-1.htm EX-99.1 6176
3 EXHIBIT 99.4 tm254155d6_ex99-4.htm EX-99.4 180846
4 EXHIBIT 99.5 tm254155d6_ex99-5.htm EX-99.5 12789
5 EXHIBIT 99.6 tm254155d6_ex99-6.htm EX-99.6 36375
6 GRAPHIC tm254155d6_ex99-4img001.gif GRAPHIC 4472
  Complete submission text file 0001104659-25-014220.txt   276102
Mailing Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014
Business Address 860 WASHINGTON STREET 3RD FLOOR NEW YORK NY 10014 2123395600
BAKER BROS. ADVISORS LP (Filed by) CIK: 0001263508 (see all company filings)

EIN.: 134093645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D

Mailing Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109
Business Address 2749 E. PARLEYS WAY SUITE 200 SALT LAKE CITY UT 84109 (801) 990-0520
SERA PROGNOSTICS, INC. (Subject) CIK: 0001534969 (see all company filings)

EIN.: 261911522 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-92704 | Film No.: 25629834
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)